NetraMark at HC Wainwright: AI pitch targets drug trial failures - Investing.com
“We categorize it as precision AI that identifies patients that are driving clinical trial successes or failures ,” Achilleos said. He also said the ...
Read the original at Investing.com ↗
- Topics
- Healthcare
- Tracked via
- “AI Falures”